Alliance Pharma hands back Xonvea rights
Some £2mln in milestone payments made to Duchesnay of Canada will be returned
Company
Alliance Pharma PLC
LON:APH
Alliance Pharma PLC is an international healthcare group, headquartered in the UK with subsidiaries in Europe, the Far East and the US and wide international reach through an extensive network of distributors, generating sales in more than 100 countries. The company holds marketing rights to around 80 Consumer Healthcare brands and Prescription Medicines, which are managed on a portfolio basis according to their growth potential.
156 stories · page 2 of 8
Alliance Pharma: Star brands and Asia underpin drugs group's financial performance
The company said it was on track to hit full-year expectations as it delivered a solid first-half performance
Alliance Pharma on track to hit full-year expectations as star brands and Asia underpin first-half performance
“Our strong underlying growth and cash generation, coupled with the enhanced banking facilities, mean we are well positioned to pursue future growth opportunities,” added CEO Peter Butterfield
Alliance Pharma happy with two-pronged strategy
“It’s a blended model of highly cash generative assets and top line growth”
Alliance Pharma sales rise as star brands perform
Sales were strong in Europe and international markets, especially China
Investments and investor services
FTSE 100 closes higher, bolstered by sterling's fall; rate rise doubts
The index of leading UK shares closed up just shy of 50 points higher at 7,676, while the FTSE 250 was also up
As Ryanair's struggles continue can easyjet look to the blue skies?
Easyjet and Severn Treant are among the key names in the diary for Wednesday.
Alliance Pharma building a head of steam in Asia Pacific
Alliance is continuing to build significant growth drivers into its business, Numis Securities asserts. The company's house broker is forecasting 10% revenue growth from 2018 to 2020
Archive
Week ahead: Investors hope Royal Mail delivers the goods and Unilever meets targets
The week ahead includes updates from Royal Mail, Unilever, Sports Direct, Rio Tinto and Anglo American along with official UK data on jobs, inflation and retail sales
Archive
Proactive news snapshot: ECR Minerals, FairFX Group, Hurricane Energy …
A glance at some of the day's highlights from the Proactive Investors newswire
Archive
Wilmington shares fall as it predicts low revenue growth
A look at some of the top risers and fallers in London on Friday
Alliance Pharma’s morning sickness drug gets marketing authorisation in the UK
The AIM-listed pharmaceutical company also said that the MHRA has approved the brand name Xonvea, which will be used for marketing Dicelctin in the UK
FTSE 100 closes in positive territory but is down on week as trade tensions continue to blight markets
Benchmarks on Wall Street are trading higher, with the Dow Jones Industrial Average up 116 points
Investments and investor services
Hvivo continues to soar as investors look ahead to next flu vaccine trial
A look at some of the biggest risers and fallers in London.
Archive
Proactive news snapshot: Taptica International, Powerhouse Energy, Haydale Graphene …
A glance at some of the day's highlights from the Proactive Investors newswire
Alliance Pharma makes £60mln swoop for Asia-Pacific rights to top-selling anti-dandruff shampoo
The new product will be the company's fourth international star brand
Investments and investor services
FTSE 100 closes in red for second day this week as Trump trade threats turn real
The market has been seeming complacent on Trump’s tough protectionist rhetoric..until now
Archive
Proactive news snapshot: Sound Energy, Alliance Pharma, Feedback …
A glance at some of the day's highlights from the Proactive Investors newswire